NCT06872320View on ClinicalTrials.gov

The Influence of Probiotics on Metabolome and Heart Rate Variability in Heart Failure of Structure Heart Disease

NAActive, not recruitingINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

March 28, 2025

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Congenital Heart DiseaseDysbiosisMalnutrition, ChildProbioticsMetabolome
Interventions
DRUG

Lactobacillus Rhamnosus

Lactobacillus Rhamnosus (Lactobacillus Rhamnosus, MoProbi-LR Capsules, Drug permit license 052531); Age \< 2 years old: 1/2 capsule once daily for 24 weeks per oral Age ≥ 2 years old: 1 capsule once daily for 24 weeks per oral

DRUG

Placebo

Maltodextrin comparable in color. Age \< 2 years old: 1/2 capsule once daily for 24 weeks per oral Age ≥ 2 years old: 1 capsule once daily for 24 weeks per oral

Trial Locations (1)

Unknown

Kaohsiung Chang Gung Memorial Hospital and Chang Gung University, Kaohsiung City

All Listed Sponsors
lead

Chang Gung Memorial Hospital

OTHER